Ervebo is a live-attenuated vaccine. That means it contains a weakened protein from EVD, which is not strong enough to cause ...

Ervebo is a live-attenuated vaccine. That means it contains a weakened protein from EVD, which is not strong enough to cause a full infection but is just enough to trigger an immune response.

The Ervebo vaccine, developed by Merck, is a single-dose vaccine. It works by using a modified virus to produce antibodies against Ebola, equipping the immune system to recognise and neutralise ...

The Ebola virus devastated west Africa in 2014, claiming over 11,000 lives in Sierra Leone, Liberia and Guinea.

The Ervebo vaccine, developed by Merck, is a single-dose vaccine. It works by using a modified virus to produce antibodies against Ebola, equipping the immune system to recognise and neutralise ...